Cargando…
Sotatercept for the treatment of pulmonary arterial hypertension: a meta-analysis of randomized controlled trials
Autores principales: | Jaiswal, Vikash, Ang, Song Peng, Agrawal, Vibhor, Borra, Vamsikalyan, Bandyopadhyay, Dhrubajyoti, Dhakal, Aayusha, DeMarco, Teresa, Fonarow, Gregg C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521901/ https://www.ncbi.nlm.nih.gov/pubmed/37767012 http://dx.doi.org/10.1093/ehjopen/oead086 |
Ejemplares similares
-
Sotatercept analog suppresses inflammation to reverse experimental pulmonary arterial hypertension
por: Joshi, Sachindra R., et al.
Publicado: (2022) -
Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension
por: Humbert, Marc, et al.
Publicado: (2023) -
Sotatercept analog improves cardiopulmonary remodeling and pulmonary hypertension in experimental left heart failure
por: Joshi, Sachindra R., et al.
Publicado: (2023) -
Idiopathic pulmonary fibrosis: Addressing the current and future therapeutic advances along with the role of Sotatercept in the management of pulmonary hypertension
por: Hadi, Dalia D., et al.
Publicado: (2023) -
Sotatercept in patients with osteolytic lesions of multiple myeloma
por: Abdulkadyrov, Kudrat M, et al.
Publicado: (2014)